Urticaria, si woyɔna be anyixe, nye ŋutigbalẽ ƒe dɔléle si me abiwo dona le ame ƒe ŋutilã ƒe akpa sia akpa.
Nu vovovowoe ate ŋu ana wòadzɔ, siwo dometɔ aɖewoe nye dɔxɔleameŋuwo, dɔlélewo, alo dɔléle bubu siwo le ame ŋu.
Atike si woazã na aɖuɖɔɖɔdɔ la anɔ te ɖe alesi dɔa nu sẽe kple nusi gbɔ wòtso dzi.
Atikewɔmɔnu siwo bɔ dometɔ aɖewoe nye esiwo gbɔna:
1. Atike siwo tsia lãmetsiwo ƒe fuɖename nu: Atike siawo ɖea lãmetsi si nye histamine, si ŋutilãa nana ne dɔléle aɖe dze ame dzi la dzi kpɔtɔna.
Atike siwo wotsɔna xea mɔ ɖe dɔléle nu abe diphenhydramine (Benadryl) alo loratadine (Claritin) ate ŋu awɔ dɔ le dɔléle siwo nu mesẽ o me.
Le amesiwo ƒe dɔa nu sẽ wu gome la, ɖɔkta ate ŋu aŋlɔ atike siwo nu sẽ wu la na wo.
2. Atike si woyɔna be corticosteroids: Ne atike siwo tsia dɔléle nu mewɔ dɔ o la, woate ŋu aŋlɔ atike si woyɔna be corticosteroids abe prednisone ene na ame be wòana eƒe lãme nagabi o eye wòana dɔlélenutsiŋutete nagbɔdzɔ.
Zi geɖe la, wotsɔa atike siawo noa nu eye woate ŋu ana ame ƒe lãme nasẽ kaba.
3. Dɔlélenutsiŋutete ƒe ŋusẽ dzi ɖuɖu: Le ŋuɖui si nɔa anyi ɣeyiɣi didi si wometea ŋu dana o gome la, woate ŋu aŋlɔ atike siwo naa ŋusẽ vɔna le dɔlélenutsiŋutete ŋu abe cyclosporine alo methotrexate ene be woatsɔ atsi dɔlélenutsiŋutete ƒe ŋusẽ nu eye woana dɔlélea dzi naɖe akpɔtɔ.
4. Omalizumab: Atike sia nye dɔlékui si woate ŋu ade lãme na si wɔa avu kple dɔlékui si nye immunoglobulin E (IgE), si nye protein si kpɔa ŋusẽ ɖe lãmetsiwo ƒe dɔwɔwɔ dzi.
Zi geɖe la, wozãnɛ na aɖuɖɔ si nu gbe tsotso si ŋu dɔdamɔnu bubuwo mewɔa dɔ ɖo o.
5. Ƒo asa na nusiwo naa woxɔa abi: Nusiwo naa abi nɔa ame ŋu nyanya kple wo ƒo asa na ate ŋu akpe ɖe ame ŋu be wòagaxɔ abi o.
Nu siwo nana dɔ sia hona na ame dometɔ aɖewoe nye nuɖuɖu aɖewo, atike aɖewo, nudzodzoeviwo ƒe ɖuɖu, dzoxɔxɔ, fafa alo ɣe ƒe keklẽ.
6. Nu fafɛ sisi ɖe teƒea: Ne èsi nu fafɛ ɖe teƒea la, ate ŋu aɖe enuléle kple enono dzi akpɔtɔ.
7. Nu si woabla ɖe nu ŋu: Woate ŋu atsɔ nu si woabla ɖe nu ŋu atsɔ atsi ŋù kple abi si le ame ŋu la nu.
Woxatsaa avɔ si me tsi le ɖe teƒea, eye emegbe wotsɔa avɔ ƒuƒui aɖe tsyɔa edzi be tsi nagage ɖe eme o.
8. Keklẽŋusẽ tsɔtsɔ da dɔe: Keklẽŋusẽ si tsoa ɣe ƒe keklẽ gbɔ ate ŋu ana dɔlélenutsiŋutete nagbɔdzɔ eye wòana aɖuɖɔdɔléle si nɔa anyi ɣeyiɣi didi la dzi naɖe akpɔtɔ.
Ele vevie be nàkpɔ atikewɔla aɖe be wòakpɔe ɖa be dɔa le ye ŋu mahã eye wòadae hã.
Woate ŋu akpe ɖe ŋuwò nànya nusi koŋ gbɔe wòtso eye woagblɔ atikewɔwɔ si sɔ na wò.
Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.
Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.
Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.
Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.
Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.
['Mɔxeɖenu: atikewɔwɔ']
['Taɖodzinu siwo nye nufiafia kple nyatakaka koe le nyatakakadzraɖoƒe sia ŋu eye menye atikewɔwɔ ŋuti ɖaŋuɖoɖo alo dɔwɔnawo ƒe nya gblɔm wole o.']
['Mele be woazã nyatakaka siwo wona la atsɔ ada dɔléle alo dɔ aɖe o, eye ele be amesiwo di be yewoakpɔ atikewɔwɔ ŋuti ɖaŋuɖoɖo na yewo la nabia ɖɔkta si xɔ mɔɖegbalẽ.']
['De dzesii be neural network si wɔa nyabiabiawo ƒe ŋuɖoɖowo la meɖia o vevietɔ ne wotsɔ xexlẽdzesiwo wɔe. Le kpɔɖeŋu me, ne wotsɔ ame siwo ŋu dɔléle aɖe le ƒe xexlẽme wɔ dɔe.']
['Bia wò ɖɔkta alo lãmesẽdɔwɔla bubu si dze ƒe aɖaŋuɖoɖo ɣesiaɣi le lãmesẽkuxi aɖe ŋu. Mègaŋe aɖaba ƒu aɖaŋuɖoɖo si ɖɔktawo ɖo na wò alo gbɔ dzi ɖi le exexlẽ me le nyatakakadzraɖoƒe sia ta o. Ne èsusu be ɖewohĩ lãmesẽkuxi aɖe le fu ɖem na ye la, ke yɔ 911 alo yi ɖe afisi wokpɔa nɔnɔme kpatawo gbɔ le.']
['Copyright: Copyright']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) na mɔ siwo dzi copyright ƒe nunɔlawo ate ŋu ato awɔ nu ɖe nu siwo wo xɔ se be wo le Internet dzi la ŋu.']
['Ne èxɔe se kple kakaɖedzi be nyatakakadzraɖoƒe alo dɔwɔnu aɖe si míetsɔ wɔ míaƒe nyatakakadzraɖoƒea alo dɔwɔnawo la nye dada le wò gome la, wò ŋutɔ (alo wò dɔtɔ) ate ŋu aŋlɔ agbalẽ aɖo ɖe mí abia be míaɖe nyatakakadzraɖoƒea alo dɔwɔnua ɖa alo axe mɔ ɖe ezazã nu.']
['Ele be woana nyatakakawo to e-mail dzi (kpɔ "Kpekpeɖeŋunaƒe" ƒe akpa si nye e-mail adrɛs). ']
['DMCA bia be nàŋlɔ nyatakaka siwo gbɔna ɖe wò nyatakaka si nèŋlɔ be woada le copyright dzi la me: (1) nuŋɔŋlɔ si fia be copyright le dɔ si ŋu wole nu ƒom le la ŋu; (2) nyatakaka si fia be nuŋɔŋlɔa le eme eye wòade mía nu be míake ɖe eŋu; (3) nyatakaka siwo ana míake ɖe ŋuwò, siwo dometɔ aɖewoe nye wò adrɛs, kaƒodzesi kple e-mail adrɛs; (4) wò nya si fia be èxɔe se kple kakaɖedzi be copyright ƒe ame si tɔe nyatakakaa nye, alo eƒe dɔtɔ, alo se aɖeke meɖe mɔ ɖe eŋu o; ']
['(5) Wò ŋutɔ nàŋlɔ agbalẽ si dzi nàde asii, si me nàde se be ne mèwɔe o la, àda alakpa, atsɔ aɖo kpe edzi be nyatakaka siwo le nyatakakaa me la de pɛpɛpɛ eye be ŋusẽ le asiwò be nàʋli agbalẽ siwo ŋu wogblɔ le be woda le la ta.']
['Eye (6) ame si tɔe agbalẽa nye alo ame si wona ŋusẽe be wòawɔ dɔ le ame si tɔ ŋkɔ me la ƒe asinuŋɔŋlɔ alo eƒe asinuŋɔŋlɔ si le mɔ̃ dzi. ']
['Ne mèŋlɔ nyatakaka siwo katã le etame ɖe agbalẽa me o la, ate ŋu ana be wò nyatoƒoe me dzodzro natsi megbe.']
['Kadodo']
['Taflatse ɖo email ɖe mí ne nyabiabia alo aɖaŋuɖoɖo aɖe le asiwò.']
How to treat urticaria?
Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.
It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.
Treatment for urticaria depends on the severity of the condition and the underlying cause.
Here are some common treatment options:
1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.
Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.
In more severe cases, a doctor may prescribe stronger antihistamines.
2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.
These medications are usually taken orally and can provide quick relief.
3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.
4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.
It is typically used for chronic urticaria that does not respond to other treatments.
5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.
Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.
6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.
7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.
A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.
8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.
It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.
They can help determine the underlying cause and recommend the most appropriate treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Le Eŋu']
['BioMedLib zãa kɔmpiuta siwo wɔa dɔ le wo ɖokui si (mɔ̃ siwo zãa mɔ̃ɖaŋunuwo tsɔ srɔ̃a nu) tsɔ wɔa nyabiabia kple ŋuɖoɖowo.']
